DarioHealth to Report Third Quarter 2021 Results on Monday, November 15
DarioHealth Corp. (NASDAQ: DRIO) is set to release its financial results for Q3 2021 on November 15, 2021, after trading. A conference call will occur on November 16, 2021, at 8:30 AM ET. Key executives including CEO Erez Raphael will lead the call.
Investors can dial in using the numbers 877-451-6152 (US) or 201-389-0879 (international). The webcast will be accessible [here](https://viavid.webcasts.com/starthere.jsp?ei=1511170&tp_key=13b2851117). Replays will be available until December 16, 2021.
- None.
- None.
NEW YORK, Nov. 8, 2021 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO), a pioneer in the global digital therapeutics market, today announced it would release its financial results for the third quarter ended September 30, 2021 on Monday, November 15, 2021, after the close of trading. The company will host a conference call and webcast on Tuesday, November 16, at 8:30 am Eastern Time.
Erez Raphael, Chief Executive Officer, Rick Anderson, President and General Manager of North America, and Zvi Ben-David, Chief Financial Officer will host the call.
Conference Call Details
Date: Tuesday, November 16, 8:30am EDT
Dial-in Number: 877-451-6152
International Dial-in: 201-389-0879
Conference ID: 13724897
Conference title: DarioHealth Third Quarter 2021 Results Call
Webcast: https://viavid.webcasts.com/starthere.jsp?ei=1511170&tp_key=13b2851117
Participants are asked to dial-in approximately 10 minutes prior to the start of the event. A replay of the call will be available approximately two hours after completion through December 16, 2021. To listen to the replay, dial 844-512-2921 (domestic) or 412-317-6671 (international) and use replay passcode 13722168. The webcast archive will be available for two months.
About DarioHealth Corp.
DarioHealth Corp. (NASDAQ: DRIO) is a leading global digital therapeutics company revolutionizing how people with chronic conditions manage their health. DarioHealth offers one of the most comprehensive digital therapeutics solutions on the market - covering multiple chronic conditions including diabetes, hypertension, weight management, musculoskeletal and behavioral health within one integrated technology platform.
Dario's next-generation, AI-powered, digital therapeutic platform supports more than just an individual's disease. Dario provides adaptive, personalized experiences that drive behavior change through evidence-based interventions, intuitive, clinically proven digital tools, high-quality software, and coaching to help individuals improve health and sustain meaningful outcomes.
Dario's unique user-centric approach to product design and engagement creates an unparalleled experience that is highly rated by users and delivers sustainable results.
The company's cross-functional team operates at the intersection of life sciences, behavioral science, and software technology and utilizes a performance-based approach to improve its users' health.
On the path to better health, Dario makes the right thing to do the easy thing to do. To learn more about DarioHealth and its digital health solutions, or for more information, visit http://dariohealth.com.
DarioHealth Corporate Contact:
Suzanne Bedell
VP Marketing
suzanne@dariohealth.com
+1-347-767-4220
Investor Relations Contact:
Chuck Padala
chuck@lifesciadvisors.com
+1-646-627-8390
Media Contact:
Josephine Galatioto
Josephine.galatioto@russopartnersllc.com
+1-212-845-4262
View original content:https://www.prnewswire.com/news-releases/dariohealth-to-report-third-quarter-2021-results-on-monday-november-15-301418310.html
SOURCE DarioHealth Corp.
FAQ
When will DarioHealth report its Q3 2021 financial results?
What time is the DarioHealth conference call for Q3 results?
Who will host the DarioHealth Q3 2021 earnings call?
How can I listen to the DarioHealth earnings call?
Until when will the DarioHealth earnings call replay be available?
What is the ticker symbol for DarioHealth?
